Division of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Seoul, Republic of Korea.
Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
JACC Cardiovasc Interv. 2015 Aug 24;8(10):1297-1307. doi: 10.1016/j.jcin.2015.04.015.
This study investigated the impact of final kissing ballooning (FKB) after main vessel (MV) stenting on outcomes in patients with coronary bifurcation lesions after application of the 1-stent technique.
Although FKB has been established as the standard method for bifurcation lesions treated with a 2-stent strategy, its efficacy in a 1-stent approach is highly controversial.
This study enrolled 1,901 patients with a bifurcation lesion with a side branch diameter ≥2.3 mm, treated solely with the 1-stent technique using a drug-eluting stent from 18 centers in Korea between January 1, 2003 and December 31, 2009. The primary outcome was major adverse cardiac events (MACE)-cardiac death, myocardial infarction, or target lesion revascularization. Propensity score-matching analysis was also performed.
FKB was performed in 620 patients and the post minimal lumen diameter of the MV and side branch was larger in the FKB group than in the non-FKB group. During follow-up (median 36 months), the incidence of MACE (adjusted hazard ratio [HR]: 0.68, 95% confidence interval [CI]: 0.46 to 0.99; p = 0.048) was lower in the FKB group than the non-FKB group. After propensity score matching (545 pairs), the FKB group had a lower incidence of MACE (adjusted HR: 0.50, 95% CI: 0.30 to 0.85; p = 0.01), and target lesion revascularization in the MV (adjusted HR: 0.51, 95% CI: 0.28 to 0.93; p = 0.03) and both vessels (adjusted HR: 0.47, 95% CI: 0.25 to 0.90; p = 0.02) than in the non-FKB group.
In coronary bifurcation lesions, we demonstrated that the 1-stent technique with FKB was associated with a favorable long-term clinical outcome, mainly driven by the reduction of target lesion revascularization in the MV or both vessels as a result of an increase in minimal lumen diameter. (Korean Coronary Bifurcation Stenting Registry II [COBIS II]: NCT01642992).
本研究旨在探讨在应用 1 支架技术治疗冠状动脉分叉病变后,主血管(MV)支架置入后行最终球囊扩张(FKB)对分叉病变患者结局的影响。
尽管 FKB 已被确立为分叉病变 2 支架策略的标准方法,但在 1 支架方法中的疗效仍存在很大争议。
本研究纳入了 2003 年 1 月 1 日至 2009 年 12 月 31 日期间,韩国 18 个中心使用药物洗脱支架治疗的 1901 例侧支直径≥2.3mm 的分叉病变患者,均采用 1 支架技术治疗。主要终点为主要不良心脏事件(MACE)-心脏死亡、心肌梗死或靶病变血运重建。同时进行了倾向评分匹配分析。
在 620 例患者中进行了 FKB,MV 和侧支的最小管腔直径在 FKB 组中大于非 FKB 组。在随访期间(中位数 36 个月),FKB 组的 MACE 发生率(校正风险比[HR]:0.68,95%置信区间[CI]:0.46 至 0.99;p=0.048)低于非 FKB 组。经倾向评分匹配(545 对)后,FKB 组 MACE(校正 HR:0.50,95%CI:0.30 至 0.85;p=0.01)和 MV 靶病变血运重建(校正 HR:0.51,95%CI:0.28 至 0.93;p=0.03)发生率较低,以及两支血管(校正 HR:0.47,95%CI:0.25 至 0.90;p=0.02)。
在冠状动脉分叉病变中,我们证明了 FKB 联合 1 支架技术与良好的长期临床结局相关,主要归因于最小管腔直径增加导致 MV 或两支血管的靶病变血运重建减少。(韩国冠状动脉分叉支架注册研究 II [COBIS II]:NCT01642992)。